Affordable Drug Manufacturing Act of 2023

Bill 118 s 3398, also known as the Affordable Drug Manufacturing Act of 2023, is a piece of legislation introduced in the US Congress with the aim of addressing the rising costs of prescription drugs. The bill seeks to promote competition in the pharmaceutical industry by allowing the government to manufacture and sell generic versions of certain high-cost drugs.

Under the Affordable Drug Manufacturing Act, the government would be authorized to produce generic versions of drugs that are deemed to be essential for public health and have seen significant price increases. This would help to lower the cost of these medications and make them more accessible to patients who rely on them for their health and well-being.

In addition to promoting competition in the pharmaceutical market, the bill also includes provisions to increase transparency in drug pricing and to prevent price gouging by pharmaceutical companies. It aims to hold drug manufacturers accountable for their pricing practices and ensure that patients are not being unfairly burdened by the high cost of prescription medications. Overall, the Affordable Drug Manufacturing Act of 2023 is a comprehensive piece of legislation that seeks to address the issue of high drug prices in the United States. By promoting competition, increasing transparency, and preventing price gouging, the bill aims to make prescription medications more affordable and accessible to all Americans.